Fully integrated CDMO serving biotech and pharmaceutical clients with end-to-end development and manufacturing for gene therapies, APIs, and large- and small-molecule products. Provides platforms and capabilities—protein expression, oligonucleotide synthesis, antibody–drug conjugates, HPAPI, biocatalysis and continuous-flow manufacturing—from preclinical/pilot programs to commercial scale.